A Cross-Sectional Survey to Investigate the Willingness, Confidence, and Feasibility of Pharmacists Prescribing Antidiabetic Medicines

Authors

  • Mathew John Donato
  • John Roy Faustino Marcos
  • Huynh Xuan Mai Tran
  • Jaimy Jose

DOI:

https://doi.org/10.55136/apsj318

Keywords:

Pharmacist prescribing, Antidiabetic medication, Diabetes

Abstract

Background: Pharmacist prescribing is undergoing trials in Australia for acute ailments such as uncomplicated urinary tract infections. However, considering the rising prevalence of chronic conditions in Australia and its significant burden on the healthcare system, pharmacist prescribing should also be explored in managing chronic diseases like diabetes.

Aim: This study aims to investigate the willingness, confidence, and feasibility of pharmacists in prescribing antidiabetic medications.

Methods: A cross-sectional survey was conducted from June to September 2023, targeting pharmacists, and intern pharmacists in New South Wales.

Results: Out of 77 candidates who expressed interest in the study, 32 (41.6% response rate) completed the survey.  Results revealed that 68.8% were willing to prescribe antidiabetic medications if permitted, regardless of the rurality of work and years of experience. Most (78.1%) were confident in their ability to offer this service, foreseeing benefits for patient health and their careers. While easy access to diabetes training seemed key for implementation, workload from current commitments emerged as a significant barrier.

Discussion: Pharmacists are overall willing and confident to prescribe antidiabetic medications if implemented. Ensuring access to adequate training and addressing workload concerns will be pivotal in establishing this service's feasibility for pharmacists.

References

Australian Institute of Health and Welfare. Diabetes prevalence in Australia: an assessment of national estimates (updated 2023 Dec 14; cited 2023 Nov 20). Website, available from: https://www.aihw.gov.au/reports/diabetes/diabetes-prevalence- australia-assessment/summary

Hughes JD, et al. (2017). The role of the pharmacist in the management of type 2 diabetes: current insights and future directions. Integr Pharm Res Pract, 16(6),15-27. Doi 10.2147/IPRP. S103783

Krass I, et al. (2007). The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med, 24(6), 677-83. Doi 10.1111/j.1464- 5491.2007.02143

Dhippayom T, et al. (2015). Supporting self-management of type 2 diabetes: is there a role for the community pharmacist? Patient Prefer Adherence, 31(9),1085-92. Doi 10.2147/PPA.S88071 5. Famiyeh IM, et al. (2017). Pharmacist prescribing: A scoping review about the views and experiences of patients and the public. Res Social Adm Pharm, 13(1),1-16. Doi 10.1016/j. sapharm.2016.01.002

Hoti K, et al. (2010). An evaluation of Australian pharmacist's attitudes on expanding their prescribing role. Pharm World Sci, 32(5), 610-621. Doi 10.1007/s11096-010-9400-2

Nissen L, et al. (2022). The management of urinary tract infections by community pharmacists: A state-wide trial: Urinary Tract Infection Pharmacy Pilot - Queensland (Outcome Report). Queensland University of Technology.

Deeks LS, et al. (2018). The Role of Pharmacists in General Practice in Asthma Management: A Pilot Study. Pharmacy (Basel, Switzerland), 6(4), 114. Doi 10.3390/pharmacy6040114

Australian Pharmacy Council (2023). Accreditation standards for pharmacist prescriber education programs - Environmental scan and literature review. APC

Jebara T, et al. (2018). Stakeholders' views and experiences of pharmacist prescribing: a systematic review. Br J Clin Pharmacol, 84(9),1883-1905. Doi 10.1111/bcp.13624

Al Hamarneh YN, et al. (2013). Pharmacist intervention for glycaemic control in the community (the RxING study). BMJ Open, 3(9):e003154. Doi 10.1136/bmjopen-2013-003154

Hoti K, et al. (2013). Expanded prescribing: a comparison of the views of Australian hospital and community pharmacists. Int J Clin Pharm, 35(3),469-75. Doi 10.1007/s11096-013-9766

Le P, et al. (2018). Collaborative pharmacist prescribing within the opioid substitution treatment program in South Australia: Patient and pharmacist views. Res Social Adm Pharm, 14(2), 187-195. Doi 10.1016/j.sapharm.2017.02.017

Bessell T, et al. (2005). Improving Australians’ access to prescription medicines: proposed practice models. Pharmacy Canberra: Guild of Australia.

Javanparast S, et al. (2020). Health service access and utilisation amongst culturally and linguistically diverse populations in regional South Australia: a qualitative study. Rural Remote Health, 20(4), 5694. Doi 10.22605/RRH5694

Kay OC, et al. (2006). Pharmacist prescribing activities— an electronic survey on the opinions of Australian pharmacists. J Pharm Pract Res, 36(3),199–203. Doi 10.1002/j.2055-2335.2006. tb00607.x

Ogundipe A, et al. (2023). The case to improve technologies for pharmacists’ prescribing. Int J Pharm Pract., 31(1), 113-115. Doi 10.1093/ijpp/riac075

Hava C. Australian pharmacists on the world stage. Australian Pharmacist, Edition 2019 Sep 19, 42(7),16-25.

University of Otago. Postgraduate certificate in pharmacist prescribing (updated 2023; cited 2023 Nov 20). Website, available from:http://www.otago.ac.nz/pharmacy/postgraduate/ professionalprogrammes/pgcertpharmpres/

Pharmacy Council (2021) Workforce Demographic Report . Pharmacy Council New Zealand.

Raghunandan R, et al. (2021). Identifying Community Pharmacist Preferences for Prescribing Services in Primary Care in New Zealand: A Discrete Choice Experiment. Appl Health Econ Health Policy, 19(2), 253-266. Doi 10.1007/s40258-020-00615-3

Urinary Tract Infections NSW Resources (updated 2024 Jan 9; cited 2024 Jan 15). Website, available from: www.psa.org.au/ resource/uti-resources-nsw/

New South Wales Government. Information for Pharmacists About the NSW Pharmacy Trial (updated 2024 Jan 9; cited 2024 Jan 15). Website, available from: www.health.nsw.gov.au/pharmaceutical/Pages/cp-pharmacists-Information.aspx

Robinson J (2018). The trials and triumphs of pharmacist independent prescribers. Pharm J, 300(7911). Doi 10.1211/ PJ.2018.20204489

Zhou M, et al. (2019). Barriers to pharmacist prescribing: a scoping review comparing the UK, New Zealand, Canadian and Australian experiences. Int J Pharm Pract, 27(6), 479-489. Doi 10.1111/ijpp.12557

McCann LM, et al. (2015). A patient perspective of pharmacist prescribing: 'crossing the specialisms-crossing the illnesses'. Health Expect, 18(1), 58-68. Doi 10.1111/hex.12008

Downloads

Published

01.03.2024

Issue

Section

Articles